About Biologos
Biologos is a company based in Chicago (United States) founded in 1976 was acquired by Ampersand Capital in March 2024.. The company has 26 employees as of December 31, 2022. Biologos offers products and services including Buffers, Cell Culture Media, Enzymes, Reagents, and Salt Solutions. Biologos operates in a competitive market with competitors including Abcam, Stem Cell Technologies, GenScript, Sino Biological and Miltenyi Biotec, among others.
- Headquarter Chicago, United States
- Employees 26 as on 31 Dec, 2022
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
-
Investors
Evolve Capital
& 2 more
-
Employee Count
26
as on Dec 31, 2022
-
Acquired by
Ampersand Capital
(Mar 20, 2024)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Biologos
Biologos offers a comprehensive portfolio of products and services, including Buffers, Cell Culture Media, Enzymes, Reagents, and Salt Solutions. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Chemical buffers for biochemical and molecular applications
Nutrient media for cell growth in biopharma processes
Enzymes for diagnostic and tissue processing tasks
Custom reagents for various scientific applications
Solutions for cell and gene therapy procedures
Unlock access to complete
Funding Insights of Biologos
- Total Funding Total Funding
- Total Rounds 1
- Last Round Last Round
- First Round First Round
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov, 2015 | Amount | Private Equity Round - Biologos | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Biologos
Biologos has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include Evolve Capital, Praesidian Capital and Ampersand Capital Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location | |
|
Praesidian Capital is focused on private equity investments in lower middle market businesses.
|
Founded Year | Domain | Location | |
|
Ampersand Capital Partners is focused on investments in healthcare and life sciences.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Biologos
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Biologos
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Biologos Comparisons
Competitors of Biologos
Biologos operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Abcam, Stem Cell Technologies, GenScript, Sino Biological and Miltenyi Biotec, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Biological reagents and antibodies are developed for life science research.
|
|
| domain | founded_year | HQ Location |
Developer of cell culture media and ancillary reagents for life science research
|
|
| domain | founded_year | HQ Location |
Reagents and instruments are provided for life sciences research.
|
|
| domain | founded_year | HQ Location |
Reagents and kits are provided for clinical research applications.
|
|
| domain | founded_year | HQ Location |
Develops tools and products for research and clinical application
|
|
| domain | founded_year | HQ Location |
Provider of molecular diagnostic kits for cancer, hereditary diseases, and reproductive disorders
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Biologos
When was Biologos founded?
Biologos was founded in 1976 and raised its 1st funding round 39 years after it was founded.
Where is Biologos located?
Biologos is headquartered in Chicago, United States. It is registered at Chicago, Illinois, United States.
How many employees does Biologos have?
As of Dec 31, 2022, the latest employee count at Biologos is 26.
What does Biologos do?
Founded in 1976 and based in Chicago, United States, Biologos operates in the biologics manufacturing sector. Standard and custom cell culture media, buffers, reagents, and sera are produced for research purposes. Quick-turn formulation, manufacturing, and distribution services are provided to support scientific applications across various research needs.
Who are the top competitors of Biologos?
Biologos's top competitors include Abcam, Sino Biological and RoosterBio.
What products or services does Biologos offer?
Biologos offers Buffers, Cell Culture Media, Enzymes, Reagents, and Salt Solutions.
Who are Biologos's investors?
Biologos has 3 investors. Key investors include Evolve Capital, Praesidian Capital, and Ampersand Capital Partners.